Base to Base biotech podcast 79: Fragile X syndrome and Parkinson’s disease
Novel cancer therapy blocks communication between cancer cells and cancer-associated fibroblasts
Retinitis pigmentosa cell therapy drug cleared for clinical trials in US and China
How cells fight back after bacterial toxins break through
Saudi Arabia looks to global biotech collaboration
Targeting NK cells may mean more effective immunotherapy in resistant tumours
Base to Base biotech podcast 14: How to build reputation, and treating spastic paraplegia 47
Time to optimise novel cell-based mRNA therapeutics reduced by more than 90%
New hypertension pill gets FDA approval
Sofinnova Partners and NVIDIA look to accelerate European life sciences startups
I-Corps Hub West accelerates deeptech commercialisation in western US
Stargardt disease targeted with $135m SpliceBio financing